Share
Journal Information
Issue
Vol. 47. Issue 4.Pages 319-432 (April 2024)
Originales
Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system
Antonio Z. Gimeno-García, Anjara Hernández-Pérez, Federica Benítez, Noemi Segura, David Nicolás-Pérez, Enrique Quintero, Noemi Hernández-Álvarez, Isabel Betancor, ... Manuel Hernández-Guerra
Gastroenterol Hepatol. 2024;47:319-26
Impact of biliary stents in the performance of the EUS-guided tissue acquisition: A systematic review and meta-analysis
Edson Guzmán-Calderón, Alfonso Chacaltana, Carlos Díaz-Arocutipa, Ramiro Díaz, Ronald Arcana, José Ramón Aparicio
Gastroenterol Hepatol. 2024;47:327-36
Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi
Rocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil
Gastroenterol Hepatol. 2024;47:337-46
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis
Iago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada
Gastroenterol Hepatol. 2024;47:347-51
Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway
Yanghui Bi, Liping Zhang, Yan Song, Lijun Sun, Michael W. Mulholland, Yue Yin, Weizhen Zhang
Gastroenterol Hepatol. 2024;47:352-65
Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signaling
Yingwei Zhu, Hong Tang, Han Zhao, Jian Lu, Kai Lin, Jingbin Ni, Bo Zhao, Gaojue Wu, Chunxiao Tan
Gastroenterol Hepatol. 2024;47:366-76
Cartas científicas
Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumab
Fiorella Cañete, Laura Gonzalez-Gonzalez, Eugeni Domènech
Gastroenterol Hepatol. 2024;47:377-8
Carcinoma medular gástrico: una variante histológica muy infrecuente
David Hernandez Bermejo, Silvia Carbonell Morote, Cristina Alenda, Sergio Ortiz, Ester Gracia, Emilio Ruiz de la Cuesta, Jose Luis Estrada, Jose Manuel Ramia
Gastroenterol Hepatol. 2024;47:378-9
Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis
Esteban Fuentes-Valenzuela, Ana Yaiza Carbajo, Samuel Juan Fernández-Prada, Beatriz Madrigal Rubiales, Natalia Carpizo Jimenez
Gastroenterol Hepatol. 2024;47:380-1
Glomerulonefritis fibrilar extrarrenal como nueva etiología de enfermedad hepática avanzada
Carlos Alventosa Mateu, Ana Vilar Gimeno, Irene Pérez Álvarez, Javier Carbonell Zamorano, Inmaculada Castelló Miralles, Mercedes Latorre Sánchez, Juan José Urquijo Ponce, Encarnación Martínez Leandro, ... Moisés Diago
Gastroenterol Hepatol. 2024;47:381-3
Imágenes del mes
Endoscopic resection of a large symptomatic duodenal lipoma
Luka Strnisa, Samo Plut, Sasa Golob, Aleksandar Gavric
Gastroenterol Hepatol. 2024;47:384-6
What shall we do with yellowish rectal lesions during screening colonoscopy?
Vincent Zimmer
Gastroenterol Hepatol. 2024;47:387-8
Quiste de duplicación entérica como presentación poco frecuente de abdomen agudo en adulto
Gerard Rafart, Clara Bassaganyas, Xavier Morales, Míriam Cuatrecasas, Jordi Rimola
Gastroenterol Hepatol. 2024;47:389-90
Cartas al director
Ischemic colitis due to Kayexalate crystals
Berta Lopez-Saez, Alex Casalots, Eva Ballesteros, Eduard Brunet-Mas
Gastroenterol Hepatol. 2024;47:391-2
Rincón joven
MASLD biomarkers: Are we facing a new era?
Douglas Maya-Miles, Javier Ampuero, David Martí-Aguado, Andrés Conthe, Rocío Gallego-Durán
Gastroenterol Hepatol. 2024;47:393-6
Artículo especial
MSH3-related adenomatous polyposis in a patient with the negative family history of colorectal polyps
Aleksandar Gavric, Mateja Krajc, Luka Strnisa, Ana Ursula Gavric, Samo Plut
Gastroenterol Hepatol. 2024;47:397-400
Documento de consenso
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, ... María-Carlota Londoño
Gastroenterol Hepatol. 2024;47:401-32
Publish in
Gastroenterología y Hepatología
Special content about COVID-19
- Implicaciones pronósticas de las alteraciones de la bioquímica hepática en los pacientes hospitalizados por COVID-19
- Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina
- Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII)
- A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Free access articles
Gastroenterol Hepatol. 2022;45:304-14
Gastroenterol Hepatol. 2022;45:231-48
Gastroenterol Hepatol. 2022;45:9-17
Gastroenterología y Hepatología follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals